Showing posts with label letters. Show all posts
Showing posts with label letters. Show all posts

Wednesday, September 24, 2014

FDA Issues Warning Letters Against Companies Selling `Ebola Cures’

image
Credit CDC PHIL

 

# 9008

 

 

Early in the 20th century electrical shock devices were used by doctors, and sold to the public, as supposed `cures’ for a variety of ailments both real and imaginary.  By the 1950s, when everything modern was `atomic’, people paid money to sit in uranium mines to soak up radon gas to `cure cancer’ or TB, or whatever might ail them. 


Throughout history there have always been claims for mineral springs, medical devices, special foods, talismans, or supplements that they can cure a variety of ills.


Some, like making tea from willow bark (it contains salicylic acid, the active ingredient in aspirin), are actually based on science – although dosing and possible side effects are problematic with this approach. 

 

But most are pure bunkum - and either have no therapeutic value - or in some cases, can actually be dangerous.  As long as there are desperate people looking for relief from illness, there will always be a ready market for all sorts of quack medicine and devices.


The FDA is the US agency in charge of regulating the drug industry, and today they have issued letters to three suppliers who are selling items they claim can either cure, or prevent, Ebola infection.  Among the usual suspects in today’s roundup are `nano silver and a variety essential oils’, all  with claims of curing everything from Ebola to PMS.


Here is the announcement, with embedded links to the letters sent to these distributors.  These letters are both detailed and specific regarding the claims being made.

 

 

2014 Ebola Outbreak in West Africa

September 24, 2014 – FDA has issued Warning Letters to three firms marketing products that claim to prevent, treat or cure infection by the Ebola virus: Natural Solutions Foundation, Young Living, and dōTERRA International LLC.  There are currently no FDA-approved vaccines or prescription or over-the-counter drugs to prevent or treat Ebola. Individuals and companies promoting these unapproved and fraudulent products must take immediate action to correct or remove these claims or face potential FDA action. 


Experimental Ebola vaccines and treatments are in the early stages of product development, have not yet been fully tested for safety or effectiveness, and the supply is very limited. There are no FDA-approved treatments for Ebola available for purchase on the Internet. A claim that a product prevents, treats, or cures a disease requires prior approval by FDA.

Tuesday, December 31, 2013

Hong Kong: Epidemiological Update & Letter To Doctors On H9N2 Case

image

Credit Hong Kong’s CHP

 



# 8115

 

Although not considered as serious as H7N9 or H5N1, the announcement yesterday (see Hong Kong: Isolation & Treatment Of An H9N2 Patient) recently arrived from neighboring Shenzhen has unleashed another epidemiological investigation, and forced the medical surveillance of this patient’s recent contacts. 

 

As part of their response, late yesterday the Hong Kong CHP issued a letter to local doctors and hospitals and this morning published a follow up press release, both of which are excerpted below.

 

Our first stop, the CHP notification letter to local doctors.

 

Surveillance And Epidemiology Branch 
Our Ref. :   (116) in DH SEB CD/8/6/1 Pt.27
30 December, 2013


Dear Doctor,


A confirmed imported case of Influenza A(H9N2) infection

We are writing to inform you that we have confirmed an imported human case of influenza A (H9N2) infection  involving an 86-year-old man with underlying illnesses.  He lived in Shenzhen with his daughter and presented with low grade fever, chills, cough and sputum since 28 December, 2013. He travelled back to Hong Kong and was admitted to North District Hospital on the same day. Sputum collected on 28 December was tested positive for influenza A M gene and negative for H1/H3 and was subsequently confirmed positive for influenza A(H9N2) by Public Health  Laboratory Services Branch  (PHLSB) today. His condition is stable with fever subsided since 29 December and currently being isolated in hospital.


Investigations by the Centre for Health Protection (CHP) revealed that the patient had no recent poultry contact,  consumption of undercooked poultry, or contact with patients. His home contact is asymptomatic.

Human influenza A (H9N2) infection  is not new to Hong Kong and cases were reported in 1999, 2003, 2007, 2008 and 2009.  Unlike influenza A (H5N1) infection, previous cases with influenza A (H9N2) infection usually presented with mild illness and all recovered. According to scientific literature and local poultry surveillance data, influenza A (H9N2) virus is commonly found in the poultry population in this region and recently it was noted that it could also be transmitted by sparrows and crows.  Sporadic cases of human influenza A (H9N2) infection are anticipated in Hong Kong.


Influenza A (H9) is a statutory notifiable disease in Hong Kong. Any suspected case meeting the reporting criteria (https://ceno.chp.gov.hk/casedef/casedef.pdf) should be immediately reported to the Central Notification Office of CHP via fax (2477 2770), phone (2477 2772) or CENO On-line (www.chp.gov.hk/ceno). Please also contact the Medical Control Officer (MCO) of DH at Pager: 7116 3300 call 9179 when reporting any suspected case.


For updates on the latest situation of avian influenza, please visit CHP website at  http://www.chp.gov.hk/en/view_content/24244.html. Thank you for your ongoing support in combating communicable diseases.


Yours faithfully,

(Dr. Yonnie LAM)
for Controller, Centre for Health Protection
Department of Health

 

And as we’ve come to expect, Hong Kong’s CHP continues to provide daily updates whenever a they detect an event with potential public health ramifications.   The good news, aside from the patients mild symptoms and no signs of spread, is that preliminary genetic analysis of the virus reveals `no evidence of genetic reassortment with genes of human influenza origin or resistance to the antiviral Tamiflu.’

31 December 2013

Epidemiological investigation and follow-up actions by CHP on confirmed human case of avian influenza A(H9N2) 

The Centre for Health Protection (CHP) of the Department of Health (DH) today (December 31) provided an update on the confirmed human case of avian influenza A(H9N2) affecting a man aged 86.

"The epidemiological investigations, enhanced disease surveillance, port health measures and health education against avian influenza are all ongoing," a spokesman for the DH said.

The patient's home contact in Shenzhen has remained asymptomatic.

The 51 health-care workers (HCWs) of North District Hospital (NDH) and the ambulance service remain under medical surveillance. Among them, an HCW of NDH presented with productive cough and sore throat and the respiratory specimen tested negative for the influenza A virus upon testing by the CHP's Public Health Laboratory Services Branch (PHLSB).

The officer who handled the patient upon his entry at Lo Wu Border Control Point is also asymptomatic. He has been put under medical surveillance. So far, there are no newly located contacts.

As the patient was staying in Shenzhen for the whole incubation period, the case is classified as an imported one. The CHP has passed investigation findings to the health authority of Guangdong for follow-up.

"Upon analysis by the PHLSB, the genes of the virus were determined to be of avian origin. They do not show significant differences from avian influenza viruses detected in Hong Kong and the Mainland in recent years. There is no evidence of genetic reassortment with genes of human influenza origin or resistance to the antiviral Tamiflu. We will continue to liaise and share the gene sequence with other health authorities based on established arrangements," the spokesman remarked.

The public is advised to avoid contact with poultry and wild birds, including chickens, ducks and sparrows.

"Travellers, especially those returning from avian influenza-affected areas and provinces with fever or respiratory symptoms, should immediately wear masks, seek medical attention and reveal their travel history to doctors. Health-care professionals should pay special attention to patients who might have had contact with poultry, birds or their droppings in affected areas and provinces," the spokesman advised.

<SNIP>

Ends/Tuesday, December 31, 2013

 

Anytime public health authorities detect a novel influenza virus infection in a human, understandably alarm bells tend to go off. But we need to keep in mind that no one really knows how rare – or common – such infections really are.

 

The vast majority of people who develop `flu-like’ symptoms around the world never seek medical care, and even among the minority that do, most are never tested. Certainly not with lab tests that would pick up a novel influenza virus.

 

With enhanced surveillance in Hong Kong for both MERS-CoV and Avian H7N9 (and H5N1), however, the odds of detecting novel flu cases goes up considerably.  Whether we are seeing an actual uptick in the number of these types of infections, or are just getting better at detecting them, is something we don’t have enough data to discern.

 

But with enhanced surveillance ongoing in Hong Kong, and across Asia, for these three strains we are also gaining information about H6N1, H10N8, and nH9N2.

 

The serendipitous result of surveillance work is that you sometimes can learn a good deal about things you weren’t looking for at the time.  And that can often pay unexpected dividends further down the line.

Saturday, December 21, 2013

Texas DSHS Letter To Doctors On Influenza Outbreak

image

Credit Texas Influenza Weekly Surveillance

 

# 8097

 

While some in the media this week are hyping the recent influenza deaths in Texas (see Texas DSHS Statement On Recent Spike In Flu Activity) as the `Return of Swine Flu’, the reality is, the virus never left.

 

It has been with us since it first emerged in 2009, but has taken a backseat to the other seasonal strain - H3N2 - in North America over the past couple of years.

 

While H1N1 is no longer a pandemic virus, it can still pack a punch . . . particularly for those under the age of 65, and those with pre-existing medical conditions.  And since it hasn’t been the dominant strain in North America the past couple of years, many people have reduced immunity to it (particularly if they skipped the flu shot).

 

This week we’ve seen reports of multiple deaths in Texas, and around the nation, now attributed to the H1N1 virus.  Many others have been hospitalized with severe illness.

 

Yesterday, the Texas DSHS sent out a notice to doctors and hospitals advising them on how to test for, and treat, severe cases of flu.

 

TEXAS DEPARTMENT OF STATE HEALTH SERVICES
DAVID L. LAKEY, M.D.  COMMISSIONER
www.dshs.state.tx.us

**INFLUENZA HEALTH ALERT**


December 20, 2013


Dear Colleague: 


Statewide influenza-like illness (ILI) activity continues to increase and is above baseline levels. ILI intensity is high in Texas, and influenza is now widespread. All Texas regions have reported laboratory confirmed influenza. Over 90% of positive influenza tests reported from Texas laboratories have been typed as influenza A. Of those influenza A viruses that have been subtyped, 90% have been the 2009 pandemic H1N1 subtype. This subtype of influenza is included in this season's influenza vaccine. 

No novel influenza cases have been reported in Texas. 


No antiviral resistant influenza strains have been reported in Texas. 


Encourage patients to get vaccinated for influenza. 


Clinicians should consider antivirals even if the Rapid Influenza Diagnostic Test is negative. 

Background: Influenza viruses can be spread by large respiratory droplets generated when an infected person coughs or sneezes in close proximity to an uninfected person. Symptoms can include fever, dry cough, sore throat, headache, body aches, fatigue, and nasal congestion. Among children, otitis media, nausea, vomiting, and diarrhea are common.

Most people generally recover from illness in 1-2 weeks, but some people develop complications and may die from influenza. The highest rates of influenza infection occur among children; however, the risks for serious health problems, hospitalizations, and deaths from influenza are higher among people 65 years of age or older, very young children, and people of any age who have medical  conditions that place them at increased risk for complications from influenza (see Treatment). 


Vaccination: Everyone who is at least 6 months of age should get a flu vaccine this season. It is not too late for vaccination. There are several flu vaccine options available for the 2013-2014 flu season. All these vaccines contain the currently circulating H1N1 strain. DSHS does not recommend one flu vaccine over another, although there are special indications for some (such as a high-dose inactivated trivalent vaccine approved for persons age 65 years and older). 

The 2013-2014 trivalent influenza vaccine is made from the following three

  An A/California/7/2009 (H1N1)pdm09-like virus 
  An A(H3N2) virus antigenically like the cell-propagated prototype virus A
  A B/Massachusetts/2/2012-like virus

Rapid Lab Tests: Rapid Influenza Diagnostic Tests (RIDTs) can be useful to identify influenza virus infection, but false negative test results are common during influenza season. Clinicians should be aware that a negative RIDT result does NOT exclude a diagnosis of influenza in a patient with suspected influenza. When there is clinical suspicion of influenza and antiviral treatment is indicated, antiviral treatment should be started as soon as possible, even if the result of the RIDT is negative, without waiting for results of additional influenza testing. 


Treatment: Oseltamivir and zanamivir are chemically related antiviral medications known as neuraminidase inhibitors that have activity against both influenza A and B viruses. Early antiviral treatment can shorten the duration of fever and illness symptoms, may reduce the risk of complications and death, and may shorten the duration of hospitalization. Clinical benefit is greatest when antiviral treatment is administered early, especially within 48 hours of influenza illness onset. Decisions about starting antiviral treatment should not wait for laboratory confirmation of influenza. 


Antiviral treatment is recommended as early as possible for any patient with confirmed or suspected influenza who:


  Is hospitalized.
  Has severe, complicated, or progressive illness. 
  Is at higher risk for influenza complications. 

Persons at higher risk for influenza complications recommended for antiviral treatment include: 


  Children aged younger than 2 years.
  Adults aged 65 years and older. 
  Persons with chronic pulmonary (including asthma), cardiovascular (except hypertension alone), renal, hepatic, or hematological disease (including sickle cell disease); metabolic disorders (including diabetes mellitus); or neurologic and neurodevelopment conditions (including disorders of the brain, spinal cord, peripheral nerve, and muscle such as cerebral palsy, epilepsy [seizure disorders], stroke, intellectual disability [mental retardation], moderate to severe developmental delay, muscular dystrophy, or spinal cord injury).   Persons with immunosuppression, including that caused by medications or by HIV infection. 
  Women who are pregnant or postpartum (within 2 weeks after delivery).
  Persons aged younger than 19 years who are receiving long-term aspirin therapy.
  American Indians/Alaska Natives.
  Persons who are morbidly obese (i.e., body-mass index is equal to or greater than 40).
  Residents of nursing homes and other chronic-care facilities. 

Clinical judgment, on the basis of the patient's disease severity and progression, age, underlying medical conditions, likelihood of influenza, and time since onset of symptoms, is important when making antiviral treatment decisions for high-risk outpatients. 


Additional details regarding antiviral treatment can be found at
http://www.cdc.gov/flu/professionals/antivirals/summary-clinicians.htm

Disease Reporting Requirements/Statute: Several Texas laws (Health & Safety Code. Chapters 81, 84, and 87) require specific information regarding notifiable conditions to be provided to DSHS. Health care providers, hospitals, laboratories, schools, childcare facilities and others are required to report patients who are suspected of having a notifiable condition (Chapter 97, Title 25, Texas Administrative Code).  In Texas, influenza-associated pediatric mortality is required to be reported within one work day. Clusters or outbreaks of any disease, including influenza, should be reported immediately. Reports of influenza-associated pediatric mortality and influenza or influenza-like illness outbreak should be made to your local health department or to 1-800-705-8868.

David Lakey, M.D.
Commissioner
Texas Department of State Health Services

 

 

Some of the initial confusion with the outbreak in Texas came from reports of `negative flu tests’ among some of the patients.   As we’ve discussed often in the past, Rapid Influenza Detection Tests are quick and easy – but they aren’t always accurate (see No Doesn’t Always Mean No).

Hence the reminder by the DSHS (and the CDC, btw) that `a negative RIDT result does NOT exclude a diagnosis of influenza’.

 

For more on the limitations of RIDT tests, you may wish to revisit last year’s side-by-side comparison of 11 commercially available test kits in MMWR: Evaluating RIDTs.

 

With H1N1 prowling the nation, aided and abetted by H3N2 and Influenza B, it is particularly important to maintain good flu hygiene right now.   The CDC recommends:

  • Wash your hands often with soap and water or an alcohol-based hand rub.
  • Avoid touching your eyes, nose, or mouth. Germs spread this way.
  • Try to avoid close contact with sick people.
  • Practice good health habits. Get plenty of sleep and exercise, manage your stress, drink plenty of fluids, and eat healthy food.
  • Cover your nose and mouth with a tissue when you cough or sneeze. Throw the tissue in the trash after you use it.
  • If you are sick with flu-like illness, stay home for at least 24 hours after your fever is gone without the use of fever-reducing medicine.

And if you haven’t already gotten your flu shot, it is certainly not too late to do that as well.

Monday, December 16, 2013

Hong Kong: CHP Notification Letter To Doctors & Hospitals On Latest H7N9 Case

image

Credit CHP


# 8075

 

In their third letter in this month of December to local Doctors & Hospitals, Hong Kong’s CHP today notified local medical establishment about the latest H7N9 case detected in neighboring Guangdong Province.  This letter not only provides details on the latest case, it recaps the recent detection of the virus in live markets in Shenzhen (see HK: Notification Of Positive H7N9 Test Results From Shenzhen Bird Markets)

 

16 December, 2013
Dear Medical Superintendent,

Third Confirmed Case of Human Infection with  Avian Influenza A(H7N9) Virus in Guangdong Province


Further to our letter to you dated 6 December 2013, we would like to inform you that an additional confirmed human  case of avian influenza A(H7N9) was reported by the Guangdong Province on 15 December, 2013.  The case involves a 39-year-old man in Dongguan, Guangdong Province. The patient had onset of fever, headache and fatigue on 6 December. He was admitted to hospital on 11 December and transferred to intensive care unit on 13 December because of breathing difficulty. He is currently in critical condition. His sample was tested positive for the avian influenza A(H7N9) virus by the relevant health authority of Guangdong Province on 15 December. Fifty-three close contacts of the patient have been put under medical surveillance and no abnormalities were found among them so far.


As of 15 December, a total of 141 human cases of avian influenza A(H7N9) infection have been confirmed in  the Mainland across 10 provinces and 2 municipalities, including 47 deaths. The health authorities of Taiwan also reported one imported case from Jiangsu on 24 April. In addition, two cases of human infection with avian influenza A(H7N9) virus likely to be imported from Shenzhen of the Mainland were recorded in Hong Kong recently, making a total of 144 cases.


In addition, as part of the epidemiological investigation of the confirmed case, avian influenza A (H7N9) was also detected in three environmental samples collected from two live poultry markets in Longgang of Guangdong Province as reported by the Health and Family Planning Commission of Guangdong Province on 11 December.

The Centre for Health Protection (CHP)  of the Department of Health (DH) has been maintaining close liaison with the World Health Organization (WHO) and health authorities in the Mainland China to obtain information and monitor the latest development of the disease. According to the risk assessment of WHO (as of 7 October), most human cases have reported contact with poultry or live animal markets. As avian influenza A(H7N9) virus causes only subclinical infections in poultry, it is possible that the virus continues to circulate among poultry in Mainland China and perhaps in neighboring countries. As such, reports of additional human cases and infections  in animals would not be unexpected, especially as the Northern Hemisphere autumn approaches.

 

We would like to urge you to pay special attention to those who presented with influenza-like illness and had history of visiting wet market with live poultry or contact with poultry in affected areas especially Guangdong Province within he incubation period (i.e. 10 days before onset of symptoms). Please kindly be reminded that the list of affected areas is regularly updated and is available at the CHP website (http://www.chp.gov.hk/files/pdf/global_statistics_avian_influenza_e.pdf).


Any suspected case meeting the reporting criteria (https://ceno.chp.gov.hk/casedef/casedef.pdf) should be immediately reported to he Central Notification Office of CHP via fax (2477 2770), phone (2477 2772) or CENO On-line (www.chp.gov.hk/ceno). Please also contact the Medical Control Officer (MCO) of DH at Pager: 7116 3300 call 9179 when reporting any suspected case. DH will make arrangement to send the patient to regional public hospitals for isolation, testing and treatment. Please kindly isolate patient to minimize contact/exposure to staff and other patients and advise the patient to wear a surgical mask while waiting for transport.

For updates on the latest situation of avian influenza, please visit CHP website at 

http://www.chp.gov.hk/en/view_content/24244.html . Thank you for your ongoing support in combating communicable diseases.


Yours faithfully,
(Dr. SK CHUANG)
for Controller, Centre for Health Protection
Department of Health

 

Tuesday, December 03, 2013

HK CHP: Notification Letter To Doctors On H7N9 Case

image

 

 

# 8034

 

One of the reason’s Hong Kong’s CHP is so well regarded among bloggers is they proactively release information to the public that other public health agencies might try hide, or at least gloss over.  Such was the case yesterday with the rapid confirmation of Hong Kong’s first (likely, imported) case of H7N9 (see Video: HK Officials Seeking Traveling Companion Of H7N9 Patient).

 

Today, HK’s CHP openly published a letter to local doctors and hospitals with additional details on this case, which provides us with the most detailed timeline of this patient’s illness and diagnosis to date.

 

Our Ref. :   (102) in DH SEB CD/8/6/1 Pt.27                                                 3 December, 2013

Dear Doctors,


A Confirmed case of Human Infection with Avian Influenza A(H7N9) virus and Activation of Serious Response Level of Government’s Preparedness Plan I would like to draw your attention to a confirmed case  of human infection with avian influenza A(H7N9) virus in Hong Kong. The patient  is a 36-year-old Indonesian maid. She lives with her employer's family (six family members)  in Tuen Mun in Hong Kong.

 

She had onset of cough on 21 November 2013 and developed fever on 22 November. She sought medical attention from two general practitioners on 25 and 26 November.  She developed shortness of breath on 27  November and attended Accident and Emergency Department of Tuen Mun hospital (TMH) and chest X-ray on admission showed right lower lobe consolidation.  She was admitted to TMH and was transferred to intensive care unit for treatment on 29 November.  Her condition deteriorated and she was transferred to Queen Mary Hospital for extracorporeal membrane oxygenation on 30 November by ambulance.

 

Her nasopharyngeal swabs and aspirates were tested positive by polymerase chain reaction (PCR) for influenza A and H7 and N9 on 2 December, confirming the diagnosis of influenza A (H7N9) by Public Health Laboratory Services Branch (PHLSB) of the Centre for Health Protection (CHP).  Her current condition is critical.

 

Preliminary epidemiological investigation revealed that the patient went to Shenzhen of Guangdong Province on 17 November for a day trip. She bought a live chicken in a market and ate after cooking  with a friend in Shenzhen. CHP of the Department of Health (DH) is communicating with the Guangdong Health Department to investigate the source of her infection. According to available information, this is likely to be an imported infection. CHP is tracing the exposed close contacts of the patients and will provide them with chemoprophylaxis and put them under quarantine. So far, four of the close contact had symptoms including cough, runny nose or sore throat and have been isolated in hospital. Investigation is on-going.

The Government has raised the influenza response level from “Alert” Response Level to “Serious” Response Level under the Framework of Government’s Preparedness Plan for Influenza Pandemic. Prior to this case, no human infections with avian influenza A(H7N9) virus were recorded in Hong Kong. According to the latest update from the National Health and Family Planning Commission of the People's Republic of China (28 November 2013), a total of 140 cases of human infection with  avian influenza A(H7N9) virus have been reported.


In response to the newly confirmed imported case in Hong Kong, we have enhanced surveillance by activating zero reporting with both public and private hospitals. We would like to urge you to pay special attention to those who presented with influenza-like illnesses and had history of visiting wet market with live poultry or contact with poultry in Guangdong Province and other affected areas within the incubation period (i.e. 10 days before onset of symptoms). Please kindly be  reminded that the list of affected areas is regularly updated and is available at the CHP website:

(http://www.chp.gov.hk/files/pdf/global_statistics_avian_influenza_e.pdf)


Any suspected case meeting the reporting criteria (https://ceno.chp.gov.hk/casedef/casedef.pdf) should be immediately reported to the Central Notification Office of CHP via  fax (2477 2770), phone (2477 2772) or CENO On-line (www.chp.gov.hk/ceno). Please also contact the Medical Control Officer (MCO) of DH at Pager: 7116 3300 call 9179 when reporting any suspected case. DH will make arrangement to send the patient to regional  public hospitals for isolation, testing and treatment. Please isolate patient to minimize contact/exposure to staff and other patients and advise the patient to wear a surgical mask while waiting for transport.

 

For updates on the latest situation of avian  influenza, please visit CHP website at http://www.chp.gov.hk/en/view_content/24244.html. Thank you for your ongoing support in combating communicable diseases.

Yours sincerely,
(Dr. SK CHUANG)
for Controller, Centre for Health Protection
Department of Health

Tuesday, March 09, 2010

ACHA Spring Break Letter

 

 

# 4414

 

The American College Health Association (ACHA) has long had an interest in pandemic preparation, prevention - and over the past year - pandemic surveillance.  

 

Their weekly update of ILI (Influenza-like-illness) activity on campuses around the country have been a ready barometer of the spread of novel H1N1 over the past year. 

 

A couple of years ago I was fortunate enough to spend three days at their 2008 annual convention on behalf of the Readymoms Alliance  talking to hundreds of visitors about pandemic issues.  

 

It was almost a year ago when tens of thousands of college spring-breakers descended upon the beaches of Mexico, this coming at a time when the novel H1N1 virus was starting to circulate widely in that region.  


While the virus would undoubtedly have spread to other countries without hitching a ride home with spring breakers, these college vacationers proved an extremely efficient form of conveyance.

 

This year, the ACHA in conjunction with the CDC, has issued a letter to students about to embark on Spring Break, urging that they avail themselves of the pandemic vaccine, and that they take common sense steps to avoid infection.

 

 

 

American College Health Association Spring Break Vaccination Letter

March 5, 2010

Don’t let influenza spoil your plans for Spring Break.

Although flu activity has declined in recent weeks, 2009 H1N1 Influenza viruses continue to spread in the United States and abroad, causing illness, hospitalizations and even deaths. Recently, several colleges and universities have reported increased influenza activity on their campuses. Flu activity is difficult to predict, but experts at the Centers for Disease Control and Prevention (CDC) expect that flu activity — caused by 2009 H1N1 or seasonal flu viruses — will continue for weeks, and parts of the world may even see big outbreaks. This season the 2009 H1N1 virus has hit young adults especially hard in terms of illness, as most young people do not have immunity to the virus. For these reasons, the CDC and the American College Health Association (ACHA) continue to encourage all students, faculty and staff at universities and colleges to protect themselves against 2009 H1N1 by getting vaccinated. In the spring of 2009, we saw the spread of 2009 H1N1 result in a lot of illness following travel associated with “Spring Break.” With the 2010 “Spring Break” coming up and large numbers of students expected to travel both domestically and internationally, getting vaccinated against 2009 H1N1 influenza is especially important.

 

The 2009 H1N1 influenza vaccine is readily available both on and off campus at school health clinics, doctor’s offices, state and local health departments and many pharmacies. Vaccination is the best way to protect yourself against 2009 H1N1 flu. And this protection is especially important if you have a health condition, such as asthma, diabetes, heart disease, pregnancy and other conditions that increase your risk of serious flu-related complications or hospitalization.

 

In addition to getting vaccinated, you can also take the following steps to help protect you from getting or spreading the flu and other illnesses while you’re on break:

  • Talk to your health care provider not only about 2009 H1N1, but also other recommended, routine vaccinations you may need if traveling, especially overseas.
  • Visit the CDC’s Travelers’ Health website (www.cdc.gov/travel) for more information and healthy travel recommendations to prevent influenza and other illnesses during travel. You can also find special information about spring break travel.
  • Stay away from people who appear sick or are coughing or sneezing. The main way the flue spreads is through the droplets of coughs and sneezes.
  • Practice good hygiene by washing your hands often with soap and water, especially after coughing and sneezing. If soap and water is not available, alcohol-based hand rubs are useful.
  • Cover your coughs and sneezes with a tissue.
  • Wash your hands often.
  • Don’t share drinking glasses or utensils – avoid drinking beverages mixed in a common container or eating after others.
  • Stay home (or away from others) if you are sick for 24 hours after your fever is gone to prevent others from getting sick too.

Spring Break is a time for rest, relaxation and fun with friends and family. Take the opportunity to get vaccinated before leaving for Spring Break and protect yourself, friends and family against 2009 H1N1 flu. Don’t let influenza spoil your plans — get vaccinated against 2009 H1N1.

Monday, September 28, 2009

Letters, I Get Letters

 

# 3779

 

 

Most of my readers by now know that while I preach individual and community preparedness, and I consider this pandemic to be a legitimate threat, I’m not exactly hyperventilating over the virulence of this H1N1 virus.

 

Swine flu appears (so far, anyway) to be a high morbidity, low mortality pandemic. It produces a lot of illness, but relatively few deaths.  A scenario we’ve discussed here for several months now.

 

That could change, of course.   But for now, 99% of those who are infected recover without incident.

 

Which means we seem poised to experience a CAT 1 pandemic, at least here in the Developed World.

 

Countries without access to antivirals, vaccines, and other modern medical resources may see something worse  (see A Tale Of Two Pandemics).

 

Not that a CAT 1 pandemic is anything to trifle with. 

 

It can, and no doubt will, exact some heavy costs over the next few months.   Absenteeism could run very high, and we may see some serious economic effects from this pandemic.

 

The impact, particularly on the Health Care Delivery system, is likely to be significant.  And I worry about my friends who are working on the front lines, for the pandemic they must deal with is likely to be different that the one most of the world experiences.

 

And of course, if you, or someone you care about, is one of the unlucky 1% who see serious complications from this virus, you will think of this pandemic as having been anything but `mild’.

 

As you might imagine, I get occasional emails and letters – some from readers, and some from friends and relatives – asking me specific questions about how to deal with pandemic issues.  

 

The best I can do is tell people how I would deal with a situation.   If they find that approach reasonable, they are free to follow suit.

 

Anyway, a few from my in-basket I thought you might find of interest.

 

A couple of weeks ago, talking to a nurse on the phone she mentioned she was going to be flying cross-country in a week.  She wondered if she should wear a surgical mask on the plane?

 

I told her I was flying to Minneapolis that same week to attend the CIDRAP conference, and I didn’t plan on wearing one.   I’d probably stuff a surgical mask in my pocket in case I was seated next to a particularly active cougher or sneezer, but doubted I would use it.

 

As it turned out, I left the mask in my carryon luggage, but never felt the need to wear one.  Even though I was seated next to a woman who reeked of cherry cough drops, and who tried to cough surreptitiously into her blanket for the 3 hour flight.

 

While I still obsessively wash (or sanitize) my hands, and try to avoid coughers and sneezers, I’m more or less resigned to the fact that if I’m susceptible, there’s little chance of avoiding exposure.  

 

This is the flu, and over the next few months it will likely become ubiquitous.  If I’m called upon to provide direct care to someone I suspect of having the flu, I would use a mask.

 

 

My Dad is 85, a cancer survivor, and has a heart condition.  He lives now with my sister who is (mumble-mumble) years older than I.  He was worried about the risks of having his great-grandchildren (who are teenagers) visiting during this fall and winter flu season.

 

As an aside, I have a friend who spent a fortune `child-proofing’  her house, but she complains they still get in . . .

 

But I digress. . . .

 

I told him there was no such thing as zero risk (hey, when you’re 85 and have bad coronary arteries, it’s risky buying green bananas or starting to watch a TV mini-series

 

If the kids are obviously sick, they should stay away. 

 

But otherwise, treat every opportunity to visit with them as a gift. There’s little point in hanging around at the age of 85 if you shut yourself up out of fear of the virus.

 

 

I was recently asked via an email whether I still advocated stockpiling food, medicines, and other supplies for 30 – 60, or even 90 days?  

 

On April 30th of this year, scarcely a week after this virus made the national spotlight, I wrote that it was probably too late to suggest that kind of preparation (See The Stockpiling Dilemma). 

 

I replied that I wholeheartedly believe that every family should strive towards better preparedness.  

 

That means having a personal disaster plan, a good first aid kit, and at least 2-weeks food and water, along with extra prescription medications on hand in case of any crisis.  But for the pandemic before us, I see no pressing need for 3 months of supplies.  

 

Quite honestly, I’ve let my 3-4 month stockpile dwindle over the past 5 months down to probably less than 60 days.  And I’m more than comfortable with that.

 

Perhaps the most interesting question came this morning, when I got an email from someone who is buying a house, and just found out her new neighbor has a pot-bellied pig as a pet. 

 

She wanted to know if that posed any special swine flu danger?

 

I told her, as long as she didn’t sneeze on the pig, it should be fine.

 

People, I said, were more likely to give the flu to the pig, than the other way around. If the pig acts sick, keep your distance for  awhile.

 

And if YOU are sick, try not to infect the pig.

 

 

But otherwise . . . unless theres' a BAR-B-Q in the little guy's immediate future . . I told her to feel free to make friends with him.

 

There you have it, a few from the mailbag that perhaps can give my readers some feel for how I’m viewing this pandemic.

 

At least today.